For instance, MALAT1 increases HMGB1 levels in hepatic injury, colorectal cancer, and multiple myeloma, often acting as a competitive endogenous RNA (ceRNA) for miRNAs that target HMGB1 [61]. Here, HMGB1 is linked to AL amyloidosis.